Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 219

1.

Risk factors for pericardial effusion after chemoradiotherapy for thoracic esophageal cancer-comparison of four-field technique and traditional two opposed fields technique.

Takata N, Kataoka M, Hamamoto Y, Tsuruoka S, Kanzaki H, Uwatsu K, Nagasaki K, Mochizuki T.

J Radiat Res. 2018 Apr 11. doi: 10.1093/jrr/rry029. [Epub ahead of print]

PMID:
29659940
2.

Kinetics of carnitine concentration after switching from oral administration to intravenous injection in hemodialysis patients.

Suzuki A, Sakai Y, Hashimoto K, Osawa H, Tsuruoka S.

Ren Fail. 2018 Nov;40(1):196-200. doi: 10.1080/0886022X.2018.1455587.

PMID:
29616582
3.

Effectiveness of Measuring Genetic Polymorphisms in Metabolizing Enzymes of Tacrolimus within One Medical Facility.

Kaneko T, Arai M, Watanabe A, Tsuruoka S.

J Nippon Med Sch. 2017;84(6):274-279. doi: 10.1272/jnms.84.274.

4.

A Case of Microscopic Polyangiitis with Subarachnoid Hemorrhage and Cardiovascular Complications.

Aratani S, Sakai Y, Tsuruoka S.

J Nippon Med Sch. 2017;84(5):251-255. doi: 10.1272/jnms.84.251.

5.

A low initial serum sodium level is associated with an increased risk of overcorrection in patients with chronic profound hyponatremia: a retrospective cohort analysis.

Aratani S, Hara M, Nagahama M, Taki F, Futatsuyama M, Tsuruoka S, Komatsu Y.

BMC Nephrol. 2017 Oct 18;18(1):316. doi: 10.1186/s12882-017-0732-1.

6.

Length, but Not Reactive Edges, of Cup-stack MWCNT Is Responsible for Toxicity and Acute Lung Inflammation.

Hamilton RF Jr., Tsuruoka S, Wu N, Wolfarth M, Porter DW, Bunderson-Schelvan M, Holian A.

Toxicol Pathol. 2018 Jan;46(1):62-74. doi: 10.1177/0192623317732303. Epub 2017 Sep 25.

PMID:
28946794
7.

Long-term complete remission in a patient with focal segmental glomerulosclerosis associated with Guillain-Barre syndrome.

Aratani S, Mii A, Yuzawa R, Morita M, Kumagai T, Sakai Y, Shimizu A, Tsuruoka S.

Nephrology (Carlton). 2017 Oct;22(10):821. doi: 10.1111/nep.12944. No abstract available.

PMID:
28921751
8.

Asporin stably expressed in the surface layer of mandibular condylar cartilage and augmented in the deeper layer with age.

Miyamoto Y, Kanzaki H, Wada S, Tsuruoka S, Itohiya K, Kumagai K, Hamada Y, Nakamura Y.

Bone Rep. 2017 Jul 23;7:41-50. doi: 10.1016/j.bonr.2017.07.002. eCollection 2017 Dec.

9.

Prevention against renal damage in rats with subtotal nephrectomy by sacubitril/valsartan (LCZ696), a dual-acting angiotensin receptor-neprilysin inhibitor.

Ushijima K, Ando H, Arakawa Y, Aizawa K, Suzuki C, Shimada K, Tsuruoka SI, Fujimura A.

Pharmacol Res Perspect. 2017 Aug;5(4). doi: 10.1002/prp2.336.

10.

Development of a novel chronic kidney disease mouse model to evaluate the progression of hyperphosphatemia and associated mineral bone disease.

Tani T, Orimo H, Shimizu A, Tsuruoka S.

Sci Rep. 2017 May 22;7(1):2233. doi: 10.1038/s41598-017-02351-6.

11.

Albuminuria predicts early neurological deterioration in patients with acute ischemic stroke.

Kanamaru T, Suda S, Muraga K, Okubo S, Watanabe Y, Tsuruoka S, Kimura K.

J Neurol Sci. 2017 Jan 15;372:417-420. doi: 10.1016/j.jns.2016.11.007. Epub 2016 Nov 5.

PMID:
27836107
12.

Utility of Ultrasonography of the Median Nerve With a High-Frequency Probe for the Diagnosis of Dialysis-Related Carpal Tunnel Syndrome.

Yamazaki T, Kawahara N, Arai K, Oyoshi K, Oshima M, Koike S, Miyauchi A, Hayasaka T, Saito T, Tsuruoka S.

Ther Apher Dial. 2016 Oct;20(5):483-491. doi: 10.1111/1744-9987.12413. Epub 2016 Mar 17.

PMID:
26991919
13.

Clinical practice guideline for drug-induced kidney injury in Japan 2016: digest version.

Usui J, Yamagata K, Imai E, Okuyama H, Kajiyama H, Kanamori H, Kaneko S, Kono E, Sakai Y, Sakai N, Sakamaki Y, Taniguchi Y, Nakai K, Nishiwaki H, Hirata S, Yamaya H, Tsuruoka S, Terada Y, Yokoyama H, Wada T, Narita I.

Clin Exp Nephrol. 2016 Dec;20(6):827-831. Review. No abstract available.

14.

Successful multitarget therapy using prednisolone, mizoribine and tacrolimus for Henoch-Schönlein purpura nephritis in children.

Ichiyama S, Matayoshi T, Kaneko T, Shimizu A, Osada SI, Watanabe A, Kanzaki A, Mitsui K, Tsuruoka S, Iwakiri K, Kawana S, Saeki H.

J Dermatol. 2017 Apr;44(4):e56-e57. doi: 10.1111/1346-8138.13614. Epub 2016 Sep 26. No abstract available.

PMID:
27667139
15.

Dialyzability of Faropenem in Infected Patients on Chronic Hemodialysis.

Hasegawa G, Tsuruoka S, Ushijima K, Maeda A, Hayasaka T, Saito T, Harada K, Fujimura A.

Ther Apher Dial. 2017 Feb;21(1):52-56. doi: 10.1111/1744-9987.12457. Epub 2016 Sep 15.

PMID:
27629941
16.

Multiwalled carbon nanotubes intratracheally instilled into the rat lung induce development of pleural malignant mesothelioma and lung tumors.

Suzui M, Futakuchi M, Fukamachi K, Numano T, Abdelgied M, Takahashi S, Ohnishi M, Omori T, Tsuruoka S, Hirose A, Kanno J, Sakamoto Y, Alexander DB, Alexander WT, Jiegou X, Tsuda H.

Cancer Sci. 2016 Jul;107(7):924-35. doi: 10.1111/cas.12954. Epub 2016 Jun 23.

17.

Disappearance of the Hummingbird Sign after Shunt Surgery in a Case of Idiopathic Normal Pressure Hydrocephalus.

Kobayashi Z, Tsuruoka S, Numasawa Y, Tomimitsu H, Shintani S.

Intern Med. 2016;55(7):815-7. doi: 10.2169/internalmedicine.55.5748. Epub 2016 Apr 1.

18.

Radical scavenging reaction kinetics with multiwalled carbon nanotubes.

Tsuruoka S, Matsumoto H, Koyama K, Akiba E, Yanagisawa T, Cassee FR, Saito N, Usui Y, Kobayashi S, Porter DW, Castranova V, Endo M.

Carbon N Y. 2015 Mar;83:232-239. Epub 2014 Oct 13.

19.

High urinary albumin/creatinine ratio at admission predicts poor functional outcome in patients with acute ischaemic stroke.

Watanabe Y, Suda S, Kanamaru T, Katsumata T, Okubo S, Kaneko T, Mii A, Sakai Y, Katayama Y, Kimura K, Tsuruoka S.

Nephrology (Carlton). 2017 Mar;22(3):199-204. doi: 10.1111/nep.12745.

PMID:
26860421
20.

Endothelial cell injury in acute and chronic glomerular lesions in patients with IgA nephropathy.

Kusano T, Takano H, Kang D, Nagahama K, Aoki M, Morita M, Kaneko T, Tsuruoka S, Shimizu A.

Hum Pathol. 2016 Mar;49:135-44. doi: 10.1016/j.humpath.2015.10.013. Epub 2015 Nov 4.

PMID:
26826420
21.

Differentiation of chemical reaction activity of various carbon nanotubes using redox potential: Classification by physical and chemical structures.

Tsuruoka S, Matsumoto H, Castranova V, Porter DW, Yanagisawa T, Saito N, Kobayashi S, Endo M.

Carbon N Y. 2015 Dec;95:302-308.

22.

Warfarin use and incidence of stroke in Japanese hemodialysis patients with atrial fibrillation.

Yodogawa K, Mii A, Fukui M, Iwasaki YK, Hayashi M, Kaneko T, Miyauchi Y, Tsuruoka S, Shimizu W.

Heart Vessels. 2016 Oct;31(10):1676-80. doi: 10.1007/s00380-015-0777-7. Epub 2015 Dec 8.

PMID:
26646256
23.

SDF1 induction by acidosis from principal cells regulates intercalated cell subtype distribution.

Schwartz GJ, Gao X, Tsuruoka S, Purkerson JM, Peng H, D'Agati V, Picard N, Eladari D, Al-Awqati Q.

J Clin Invest. 2015 Oct 26;125(12):4365-74. doi: 10.1172/JCI80225.

24.

Comparison of immunosuppressive therapies for IgA nephropathy after tonsillectomy: three-course versus one-course steroid pulse combined with mizoribine.

Kaneko T, Arai M, Ikeda M, Morita M, Watanabe Y, Hirama A, Shimizu A, Tsuruoka S.

Int Urol Nephrol. 2015 Nov;47(11):1823-30. doi: 10.1007/s11255-015-1118-6. Epub 2015 Oct 3.

25.

[Effects of long-acting insulin degludec on type 2 diabetic hemodialysis patients with poor glycemic control].

Wada K, Wada Y, Tsuruoka S.

Nihon Jinzo Gakkai Shi. 2015;57(5):872-7. Japanese.

PMID:
26387380
26.
27.

A Case of Cryoglobulinemic Membranoproliferative Glomerulonephritis Induced by Hepatitis C Virus.

Otsuka T, Sakai Y, Ohno D, Tsuruoka S.

J Nippon Med Sch. 2015;82(4):193-201. doi: 10.1272/jnms.82.193.

28.

IgA nephropathy and psoriatic arthritis that improved with steroid pulse therapy and mizoribine in combination with treatment for chronic tonsillitis and epipharyngitis.

Kaneko T, Mii A, Fukui M, Nagahama K, Shimizu A, Tsuruoka S.

Intern Med. 2015;54(9):1085-90. doi: 10.2169/internalmedicine.54.3510. Epub 2015 May 1.

29.

Blood Urea Nitrogen/Creatinine Ratio and Response to Tolvaptan in Patients with Decompensated Heart Failure: A Retrospective Analysis.

Okayama D, Suzuki T, Shiga T, Minami Y, Tsuruoka S, Hagiwara N.

Am J Cardiovasc Drugs. 2015 Aug;15(4):289-93. doi: 10.1007/s40256-015-0121-8.

PMID:
25940650
30.

Pulmonary hemorrhage associated with Henoch-Schöenlein purpura in an adult patient primary diagnosed of IgA nephropathy.

Tani T, Arima R, Kaneko T, Hayashi H, Tsuruta K, Shimizu A, Tsuruoka S.

CEN Case Rep. 2015 May;4(1):48-54. doi: 10.1007/s13730-014-0138-x. Epub 2014 Jul 22.

31.

A case of gefitinib-associated membranous nephropathy in treatment for pulmonary adenocarcinoma.

Kaneko T, Shimizu A, Aoki M, Tsuruoka S.

CEN Case Rep. 2015 May;4(1):31-37. doi: 10.1007/s13730-014-0135-0. Epub 2014 Jul 18.

32.

Glomerular endothelial cell injury and focal segmental glomerulosclerosis lesion in idiopathic membranous nephropathy.

Morita M, Mii A, Shimizu A, Yasuda F, Shoji J, Masuda Y, Ohashi R, Nagahama K, Kaneko T, Tsuruoka S.

PLoS One. 2015 Apr 15;10(4):e0116700. doi: 10.1371/journal.pone.0116700. eCollection 2015.

33.

Glomerular capillary and endothelial cell injury is associated with the formation of necrotizing and crescentic lesions in crescentic glomerulonephritis.

Fujita E, Nagahama K, Shimizu A, Aoki M, Higo S, Yasuda F, Mii A, Fukui M, Kaneko T, Tsuruoka S.

J Nippon Med Sch. 2015;82(1):27-35. doi: 10.1272/jnms.82.27.

34.

Comparison of pain and efficacy of darbepoetin alfa and epoetin Beta pegol treatment in patients receiving peritoneal dialysis.

Otsuka T, Sakai Y, Yui S, Sukegawa M, Suzuki A, Mugishima K, Sumi Y, Otsuka Y, Tsuruoka S.

J Nippon Med Sch. 2015;82(1):21-6. doi: 10.1272/jnms.82.21.

35.

Effects of nitrogen-doped multi-walled carbon nanotubes compared to pristine multi-walled carbon nanotubes on human small airway epithelial cells.

Mihalchik AL, Ding W, Porter DW, McLoughlin C, Schwegler-Berry D, Sisler JD, Stefaniak AB, Snyder-Talkington BN, Cruz-Silva R, Terrones M, Tsuruoka S, Endo M, Castranova V, Qian Y.

Toxicology. 2015 Jul 3;333:25-36. doi: 10.1016/j.tox.2015.03.008. Epub 2015 Mar 20.

36.

Association between pulse wave velocity and a marker of renal tubular damage (N-acetyl-β-D-glucosaminidase) in patients without diabetes.

Ouchi M, Oba K, Saigusa T, Watanabe K, Ohara M, Matsumura N, Suzuki T, Anzai N, Tsuruoka S, Yasutake M.

J Clin Hypertens (Greenwich). 2015 Apr;17(4):290-7. doi: 10.1111/jch.12492. Epub 2015 Feb 9.

37.

Observation of intrafraction prostate displacement through the course of conventionally fractionated radiotherapy for prostate cancer.

Hamamoto Y, Inata H, Sodeoka N, Nakayama S, Tsuruoka S, Takeda H, Manabe T, Mochizuki T, Umeda M.

Jpn J Radiol. 2015 Apr;33(4):187-93. doi: 10.1007/s11604-015-0396-3. Epub 2015 Feb 8.

PMID:
25663603
38.

Acute graft-versus-host disease of the kidney in allogeneic rat bone marrow transplantation.

Higo S, Shimizu A, Masuda Y, Nagasaka S, Kajimoto Y, Kanzaki G, Fukui M, Nagahama K, Mii A, Kaneko T, Tsuruoka S.

PLoS One. 2014 Dec 26;9(12):e115399. doi: 10.1371/journal.pone.0115399. eCollection 2014.

39.

[Diuretic agent].

Hirama A, Tsuruoka S.

Nihon Rinsho. 2014 Aug;72(8):1472-6. Review. Japanese.

PMID:
25167755
40.

Dense deposit disease in an elderly patient: report of a case.

Ohno D, Sakai Y, Suzuki A, Mugishima K, Sumi Y, Otsuka Y, Otsuka T, Shimizu A, Tsuruoka S.

J Nippon Med Sch. 2014;81(3):120-1. No abstract available.

41.

A case of neuromyelitis optica spectrum disorder with early successful induction of double filtration plasmapheresis.

Sakai Y, Otsuka T, Tsuruoka S.

Ther Apher Dial. 2014 Jun;18(3):317-8. doi: 10.1111/1744-9987.12216. No abstract available.

PMID:
24965298
42.

Clinical benefit of the change of dialysate calcium concentration from 3.0 to 2.75 mEq/L.

Sakai Y, Otsuka T, Ohno D, Murasawa T, Sakai S, Tsuruoka S.

Ther Apher Dial. 2014 Apr;18(2):181-4. doi: 10.1111/1744-9987.12099.

PMID:
24720409
43.

Effects of alogliptin in chronic kidney disease patients with type 2 diabetes.

Sakai Y, Suzuki A, Mugishima K, Sumi Y, Otsuka Y, Otsuka T, Ohno D, Murasawa T, Tsuruoka S.

Intern Med. 2014;53(3):195-203.

44.

Promotion of lung adenocarcinoma following inhalation exposure to multi-walled carbon nanotubes.

Sargent LM, Porter DW, Staska LM, Hubbs AF, Lowry DT, Battelli L, Siegrist KJ, Kashon ML, Mercer RR, Bauer AK, Chen BT, Salisbury JL, Frazer D, McKinney W, Andrew M, Tsuruoka S, Endo M, Fluharty KL, Castranova V, Reynolds SH.

Part Fibre Toxicol. 2014 Jan 9;11:3. doi: 10.1186/1743-8977-11-3.

45.

Multiple cerebral lesions as the unique complication of idiopathic retroperitoneal fibrosis.

Tani T, Ishihara C, Kaneko T, Tsuruoka S, Iino Y.

Mod Rheumatol. 2015 May;25(3):468-71. doi: 10.3109/14397595.2013.843754. Epub 2013 Nov 5.

PMID:
24252042
46.

Large area films of alternating graphene-carbon nanotube layers processed in water.

Tristán-López F, Morelos-Gómez A, Vega-Díaz SM, García-Betancourt ML, Perea-López N, Elías AL, Muramatsu H, Cruz-Silva R, Tsuruoka S, Kim YA, Hayahsi T, Kaneko K, Endo M, Terrones M.

ACS Nano. 2013 Dec 23;7(12):10788-98. doi: 10.1021/nn404022m. Epub 2013 Nov 12.

PMID:
24187970
47.

Investigation of the pulmonary bioactivity of double-walled carbon nanotubes.

Sager TM, Wolfarth MW, Battelli LA, Leonard SS, Andrew M, Steinbach T, Endo M, Tsuruoka S, Porter DW, Castranova V.

J Toxicol Environ Health A. 2013;76(15):922-36. doi: 10.1080/15287394.2013.825571.

PMID:
24156695
48.

Febuxostat for treating allopurinol-resistant hyperuricemia in patients with chronic kidney disease.

Sakai Y, Otsuka T, Ohno D, Murasawa T, Sato N, Tsuruoka S.

Ren Fail. 2014 Mar;36(2):225-31. doi: 10.3109/0886022X.2013.844622. Epub 2013 Oct 24.

PMID:
24152124
49.

Comparison of once daily versus twice daily olmesartan in patients with chronic kidney disease.

Sakai Y, Suzuki A, Mugishima K, Sumi Y, Otsuka Y, Otsuka T, Ohno D, Murasawa T, Tsuruoka S.

Int J Nephrol Renovasc Dis. 2013 Oct 11;6:223-7. doi: 10.2147/IJNRD.S52905. eCollection 2013.

50.

A new approach to design safe CNTs with an understanding of redox potential.

Tsuruoka S, Cassee FR, Castranova V.

Part Fibre Toxicol. 2013 Sep 2;10:44. doi: 10.1186/1743-8977-10-44.

Supplemental Content

Loading ...
Support Center